Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Will Pass

    News

    Endogenous retroviruses may unlock new immunotherapy targets

    Author:
    Will Pass
    Publish date: September 28, 2018

    Future epigenetic drugs could activate human endogenous retroviruses (HERVs) in cancer cells to enable immunotherapy, investigators suggest.

    ...

    • Read More

    News

    Dramatic response from pembrolizumab in patient with Lynch syndrome

    Author:
    Will Pass
    Publish date: September 24, 2018

    A woman with two distinct primary tumors caused by Lynch syndrome achieved complete regression of both after pembrolizumab therapy.

    • Read More

    News

    Brentuximab vedotin boosts elderly Hodgkin survival

    Author:
    Will Pass
    Publish date: September 23, 2018

    Adding Bv to standard chemotherapy improved survival over historical rates.

    • Read More

    News

    First combo trial of mTOR/BRAF inhibition shows potential

    Author:
    Will Pass
    Publish date: September 23, 2018

    A combination of the mammalian target of rapamycin (mTOR) inhibitor everolimus and the BRAF inhibitor vemurafenib appears safe for patients with...

    • Read More

    News

    Ulipristal reduces bleeding with contraceptive implant

    Author:
    Will Pass
    Publish date: September 22, 2018

    Dr. Eve Espey says toxicity concerns must be addressed before a clinical roll out.

    • Read More

    News

    Guideline-recommended tests’ prognostic ability affirmed in prostanoid-treated PAH

    Author:
    Will Pass
    Publish date: September 21, 2018

    Test results sorted patients into lower, intermediate, or higher risk for mortality.

    • Read More

    News

    Guideline offers comprehensive approach for ICU clinicians

    Author:
    Will Pass
    Publish date: September 19, 2018

    The guideline is comprehensive, consisting of both broad and specific descriptions of current ICU practices and associated evidence.

    • Read More

    News

    PARP inhibitor plus trabectedin shows promise for sarcoma

    Author:
    Will Pass
    Publish date: September 18, 2018

    Investigators planning phase 2 studies after phase 1b results demonstrated tolerability and efficacy with the combination of olaparib and...

    • Read More

    News

    Kymriah cost effectiveness depends on long-term outcomes

    Author:
    Will Pass
    Publish date: September 17, 2018

    The value proposition for the pricey CAR T-cell therapy depends on whether the real-world outcomes are as good as the ones seen in clinical trials...

    • Read More

    News

    Updated IPF guideline refines diagnostic criteria with HRCT

    Author:
    Will Pass
    Publish date: September 17, 2018

    Use of serum biomarkers to distinguish IPF from other lung diseases wasn’t recommended.

    • Read More

    News

    SBRT controls oligometastatic RCC in majority of patients

    Author:
    Will Pass
    Publish date: September 17, 2018

    Stereotactic body radiation therapy (SBRT) is a safe and effective treatment option for patients with oligometastatic renal cell carcinoma (RCC),...

    • Read More

    News

    Repeat MRI not useful in suspected axial spondyloarthritis

    Author:
    Will Pass
    Publish date: September 16, 2018

    Male gender and HLA-B27 positivity were found to be important predictors of a positive MRI.

    • Read More

    News

    Outpatient costs soar for Medicare patients with chronic hepatitis B

    Author:
    Will Pass
    Publish date: September 12, 2018

    Inpatient costs also increased, but less dramatically.

    • Read More

    News

    HIV-associated Kaposi sarcoma responds to checkpoint inhibitors

    Author:
    Will Pass
    Publish date: September 7, 2018

    Checkpoint inhibitor therapy is effective for patients with HIV-associated Kaposi sarcoma (KS), a recent study has found.

    Partial or...

    • Read More

    News

    POEM effective for more than achalasia

    Author:
    Will Pass
    Publish date: September 5, 2018

    Peroral endoscopic myotomy (POEM) is safe and effective for several nonachalasia esophageal motility disorders,...

    • Read More

    Pages

    • « first
    • …
    • 34
    • 35
    • 36
    • 37
    • 38
    • 39
    • 40
    • 41
    • 42
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery